Bristol-Myers
Squibb Company (NYSE:BMY) will host a teleconference on Monday, June
2, 2014, at 8 a.m. EDT (7 a.m. CDT) to review data presented at the
Annual Meeting of the American Society of Clinical Oncology (ASCO) in
Chicago. Company executives will provide an overview of data presented
at the meeting, with a focus on the company’s immuno-oncology portfolio,
and address inquiries from investors and analysts.
Investors and the general public are invited to listen to a live webcast
of the call at: http://investor.bms.com
or by dialing 913-312-0946, confirmation code: 6785698. Materials
related to the call will be available at the same website prior to the
call. A replay of the call will be available beginning at 11 a.m. EDT on
June 2 through 11 a.m. EDT on June 16. The replay can be accessed at http://investor.bms.com
or by dialing 402-280-9013, confirmation code: 6785698.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission
is to discover, develop and deliver innovative medicines that help
patients prevail over serious diseases. For more information, please
visit www.bms.com
or follow us on Twitter at http://twitter.com/bmsnews.
Copyright Business Wire 2014